World Congress on Human Genetics November 07- 08, 2016 Barcelona, Spain

.

.

Dr. Wassman is Chief Medical Officer of Lineagen, Inc., which focuses on optimized genetic diagnostic services for individuals with autism and other conditions of childhood development. A pioneer of personalized medicine, he has driven the translation and delivery of cutting-edge diagnostic technologies to clinical service for over 30-years. He has held numerous executive positions in the field of genetic testing, co-founded Good Start Genetics, and was CMO there and at Genzyme Genetics, Rosetta Genomics, Generation Health, Helicos Biosciences, Celula, and Alfigen. He is a graduate of Yale University and Albany Medical College and Board Certified in Pediatrics and Medical Genetics.

Chromosomal microarray

Dr. Michael Nova is the Chief Innovation Officer and founding team member of Pathway Genomics. He is the inventor of all wellness genetic tests, and also the Pathway-IBM/Watson mobile application: OME. His scientific career began at the Salk Institute with Nobel Laureate Roger Guillemin, researching the genetics of growth factors. Michael was the founder/CEO of wireless drug discovery company Discovery Partners Inc. (Nasdaq: DPII; $150M IPO). Dr. Nova is an IBM and Metagenics Advisory Board Member; the 2005 World Economic Forum (WEF) Technology Pioneer Award Winner; and the physician of record on the first person to have their entire genome sequenced by Illumina (2009). He has 35 issued patents, and likes to surf in Indonesia.

Type 2 diabetes (T2D) and obesity are complex disorders that constitute major public health problems. The evidence for familial aggregation of both T2D and obesity is substantial. To date, more than 150 genetic loci are associated with the development of monogenic, syndromic, or multifactorial forms of T2D or obesity; many within lipid and carbohydrate metabolism pathways. SNPs located in or near FTO, MC4R, MC3R, POMC, LEP, LEPR, PLIN1, APOA5, LIPC, FABP2, INSIG2, IRS1, GIPR, ADBR2, ADRB3, UCP1, RETN, ADIPOQ, IL6, PPARG, TCF7L2, and CLOCK, among others, are implicated in both diabetes and obesity gene networks, pleomorphic with nutritional and metabolic traits. A personalized nutritional approach, based not only on phenotypic traits but also on genetic make-up, may help to control body weight and obesity. Recent advances in nutrigenetics, bioinformatics and genome-wide association metabolomics studies are set to unleash a revolution in personalized nutrition. In this symposium, we discuss the evidence concerning the genetic contribution to individual risk of T2D and obesity, and explore the potential role of nutritional and environmental mechanisms. We also explain how genetics, epigenetics, and environment are likely to interact to define the individual risk of disease; through analyzing the results of a number of recent human clinical trial studies that use genetics to personalize treatment plans for obesity, metabolic syndrome, and diabetes management. The aim of these studies was to determine the impact of a targeted, precision treatment program on reducing a patient’s future risk of metabolic syndrome (MetS).

Born in 1940, graduated from the State Medical Institute in Lvov (Ukraina), took postgraduate courses and received a PhD degree in Saint-Petersburg (Russia) in 1976 . The Chief of laboratory for prenatal diagnosis of inherited and inborn diseases at the Ott’s Institute of Obstetrics, Gynecology & Reproduction. Interested in genetic and cytogenetic aspects of early development, gene testing of inherited predisposition to common disorders , personalized predictive medicine, gene therapy. Professor, Corresponding Member of Russian Academy of Sciences, Honorary Scientist, Chief City Expert in Medical Genetics, , The author and co-author of 29 books and over 400 scientific papers

Endometriosis , Gynecology and Obstetrics

Dr. Liu, an internationally renowned surgeon-scientist, is the Leonard M. Miller Professor and Vice Chair of Otolaryngology. He has had a career long interest in genetic deafness and has made many significant contributions. He is the author of more than 200 scientific papers in top journals. His team has discovered 15 percent of all the new genes related to deafness in the world. His exemplary translational research on hereditary hearing loss from basic sciences to clinical application (bench to bedside) for the past three years, ranking in the top 1 percent of NIH-funded physician-scientists in the auditory field.

Otolaryngology,whole genome sequencing,hearing loss (

Dr. Alexei Fedorov is an Associate Professor in the Department of Medicine and Vice Director of Bioinformatics and Proteomics/Genomics Program at the University of Toledo, Ohio, USA. He received his MS degree in Physics from Moscow State University, Russia and PhD degree in molecular genetics from the Institute of Molecular Genetics, Russian Academy of Science, Moscow. He developed his programming skills being a postdoctoral fellow in Walter Gilbert lab at Harvard. He has over a hundred publications including fifty manuscripts as a principal author. His specific areas of interest in Bioinformatics are the following: 1) Principles of mammalian genome organization; 2) Origin, evolution, and functioning of introns; 3) Structure, function, and evolution of non-coding RNA; 4) Computer modeling of the human genome evolution; 5) Distribution of SNPs in human populations.

Bioinformatics

Dr. Lyon is a professor of clinical pathology at the University of Utah’s School of Medicine and a medical director of Molecular Genetics and Genomics ARUP Laboratories. Dr. Lyon received her PhD in medical genetics at the University of Alabama at Birmingham and completed fellowships in clinical molecular genetics and molecular pathology at the University of Utah. She is certified with the American Board of Medical Genetics; and a member of the Association for Molecular Pathology, American Society of Human Genetics, American College of Medical Genetics, and the American Association for Clinical Chemistry.

Medical Genetics

Dr. Ramón Cacabelos is Professor of Genomic Medicine at Camilo José Cela University, Madrid, and President of the EuroEspes Biomedical Research Center, Corunna, Spain. He received his M.D. from Oviedo University, Ph.D. from Santiago University, and D.M.Sci. (Psychiatry) from Osaka University Medical School, Japan. After a decade at the Department of Psychiatry in Osaka, he returned to Spain and focused his research activity on the genomics and pharmacogenomics of neurodegenerative disorders. He has published over 600 papers and 24 books, and is Editor-in-Chief of the first World Guide for Drug Use and Pharmacogenomics and President of the World Association of Genomic Medicine.

Drug discovery ,Pharmacogenomics

Dr Ruszkiewicz became a Fellow of the Royal College of Pathologists of Australasia (RCPA) in 1998. He is a Senior Consultant Pathologist at SA Pathology, Head of Gastroenterology Research Laboratory, Associate Professor, School of Medicine, University of Adelaide and School of Pharmacy and Medical Science, University of South Australia. He has a special interest in the gastroenterology pathology, particularly in the precursor lesions and malignancies of the colorectum, esophagus and pancreas. He is co-founder of Colorectal Cancer Tissue Bank which holds samples of colorectal cancers, polyps, normal tissues and blood from patients with colorectal malignancies. He is an examiner for the RCPA

Cancer Genetics

Kamran Mansouri has completed his PhD in Molecular Medicine from Tehran university of Medical Sciences, Iran. He is the head of angiogenesis department of Medical Biology Research Center. He has published more than 34 papers in reputed journals.

Medical Biology,angiogenesis

Iván Tellado is Bachelor in Biological Science from University of A Coruña, Spain (1998). He is the director of Digital Diagnosis at the EuroEspes Biomedical Research Center. He has published more than 15 papers in reputed scientific journals. His scientific research has been focused on the study of the genotype-phenotype relationship on brain, in particular in age- and genotype-related changes on brain activity networks

Human Genetics

Dr. Oscar Teijido Hermida is the head of the Medical Epigenetics Department at EuroEspes Biomedical Research Center, Institute of Medical Science and Genomic Medicine, Corunna, Spain. He received his PhD in the University of Barcelona, Spain in 2007 with his Thesis titled: Biochemical characterization and location of the protein MLC1, involved in the Megalencephalic Leukoencephalopathy with Subcortical Cysts. During his scientific career in University of A Corunna (Spain), University of Barcelona (Spain), New York University (USA), and The National Institutes of Health (USA), Dr. Teijido achieved more than 20 scientific publications in the molecular genetics, biochemistry, and physiology fields and presented his work in more than 25 International Conferences and invited presentations.

Human Genetics

Mousumi Mutsuddi is working as Asst Professor in Department of Molecular and Human Genetics at Banaras Hindu University Varanasi, India

Human Genetics

Guy Fontaine has made 15 original contributions at the inception of cardiac pacemakers in the mid-60s. He has identified ARVD by serendipity in the late 70s, published 900 scientific papers including 201 book chapters. He is in the 3 books: 216 Profiles in Cardiology since the 14th century (Hurst 2003), “500 greatest Geniuses of the 21th century” (ABI) 2005 USA, the “100 Life time of Achievement” (IBC) 2005 Cambridge UK. Reviewer of 17 journals both in clinical and basic Science. He has given 11 master lectures in China (2014). He is also working on brain and heart protection in cardiac arrest and stroke by therapeutic hypothermia.

Cardiomyopathies, arrhythmias, cardiac pacemakers

Purvi Patel is an oncology scientist and is the Vice Chairman of United International Diagnostics, a state of the art diagnostic lab in India. She has done three masters with Major in Medical Biotechnology (India), Molecular Biology (Sweden) and Cancer Biology (USA). She has worked in Cancer diagnostic labs over the period of 6 years and has published several articles in renowned journals like Oncogene, Nature etc. She has been awarded for best research in women’s health at UC Denver. She received honor code certification for Entrepreneurships in developing nations and Innovating in healthcare programs at Harvard Business School, Boston, Massachusetts. Being a cancer scientist, she always wanted to start advanced cancer diagnostic pathology lab in India, which will be affordable to every person in society.

Cancer

Fabrício R. Santos is full professor at UFMG, geneticist with a PhD in 1995 at UFMG, and post-doctorate at Oxford University, UK, and National Geographic Society/Pennsylvania University, USA. He he is professor in the area of Genetics and Evolution of UFMG, Director of the Taxonomic Collections Center of UFMG, President of the Brazilian Society of Genetics, member of the Iberoamerican Academy of Evolutionary Biology, and fellow researcher of the National Research Council of Brazil. He works mainly in natural history and biological evolution using DNA and analyses of population genetics, phylogeography and phylogeny applied to biodiversity and the human species.

phylogeography,phylogeny and Genetics

Professor Byung-Dong Kim is a professor emeritus of the Seoul National University and a member of the Korean Academy of Science and Technology. He is the chair of the advisory board of the Plant Genomics and Breeding Institute of the Seoul National University. Professor Kim authored in 2008 a book entitled “Foldback Intercoil DNA” in Seoul Korea. In this book he described so far unknown structure of DNA of the same name and explained its utility in explaining the role of short repeat sequences in homologous recombination and transposition. Currently he is pioneering the biological meaning of the FBI DNA in the age of genomics and epigenetics.

Molecular Genetics

Frenkel Guisado Bourzac is Auxiliary Professor (equivalent to Associate Professor, USA) since 2015 and Assistant Professor Ranksince 2007at Faculty of Natural and Exact Sciences, University of Oriente, with more than 12 years of teaching experience.His research is focused at Biochemistry and Molecular Biology, Ecotoxicology, Enzymology, Physiology, Sport Sciences and Higher Education Curriculum, with Master of Science degree from UCCFD and PhD in progress.He has published more than 11 papers in reputed journals with 19 International Meetingsand Congresses participations where others 17 research reports have been published in CD-ROM memories and other scientific journals.

Natural and Exact Sciences,heterochronism

Dean, Faculty of Medicine from 2005 – 2009 and Program Leader of the joint Hebrew University of Jerusalem and 2009- 2014 and his Research Interests are Biology of mast cells: investigation of the molecular mechanisms involved in mast cell activation by their growth factors and by allergic stimuli; gene expression during such stimulation.

gene expression,Medicine